CliffBio
small molecule

CORTROSYN

COSYNTROPIN

Loss of exclusivity—loss of exclusivity
CompanyAmphastar Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCORTROSYN
Active ingredientCOSYNTROPIN
Strength0.25MG/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusRX

More from Amphastar Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CORTROSYN patent cliff — loss of exclusivity — | CliffBio